Pasireotide clinical trials: 45 trials
Page 1 of 1
Read 45 Pasireotide clinical trials with posted results or linked papers with results in PepBank.
- Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess
NCT00994110 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
NCT00600886 · Phase 3 · Completed
Posted results
- Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
NCT01794793 · Phase 4 · Completed
Posted results
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
NCT02060383 · Phase 4 · Completed
Posted results
- Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
NCT01137682 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
NCT00690430 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
NCT00434148 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
NCT01374906 · Phase 3 · Completed
Posted results
- Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
NCT02354508 · Phase 3 · Completed
Posted results
- An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
NCT01582061 · Phase 3 · Completed
Posted results
- Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
NCT01620138 · Phase 2/3 · Completed
Posted results
- HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications
NCT02775227 · Phase 4 · Active, not recruiting
Linked paper with results
- Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
NCT01374451 · Phase 2 · Terminated
Posted results
- 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial
NCT01563354 · Phase 2 · Completed
Posted results
- Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
NCT00958841 · Phase 2 · Terminated
Posted results
- Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
NCT01915303 · Phase 2 · Terminated
Posted results
- Pasireotide LAR in Severe Polycystic Liver Disease
NCT01670110 · Phase 2 · Completed
Posted results
- Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers
NCT01128192 · Phase 2 · Completed
Posted results
- Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors
NCT00088595 · Phase 2 · Completed
Posted results
- Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
NCT01637272 · Phase 2 · Completed
Posted results
- Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
NCT01270321 · Phase 2 · Completed
Posted results
- Pasireotide in Prevention of GI Toxicity
NCT02215070 · Phase 2 · Completed
Posted results
- Monthly SOM230C for Recurrent or Progressive Meningioma
NCT00859040 · Phase 2 · Completed
Posted results
- Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism
NCT01673646 · Phase 2 · Completed
Posted results
- An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
NCT00171730 · Phase 2 · Completed
Posted results
- Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
NCT01253161 · Phase 2 · Completed
Posted results
- Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
NCT01488487 · Phase 2 · Completed
Posted results
- Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
NCT01283542 · Phase 2 · Completed
Posted results
- Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma
NCT01639352 · Phase 2 · Completed
Posted results
- Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
NCT00171951 · Phase 2 · Completed
Posted results
- Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01468532 · Phase 1/2 · Completed
Posted results
- Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size
NCT02021942 · Phase 2 · Completed
Posted results
- RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
NCT01252251 · Phase 2 · Completed
Posted results
- Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
NCT01372618 · Phase 1/2 · Terminated
Posted results
- Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
NCT01313559 · Phase 2 · Terminated
Posted results
- Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
NCT02749227 · Phase 2 · Terminated
Posted results
- Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
NCT00929669 · Phase 2 · Terminated
Posted results
- Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma
NCT00813592 · Phase 2 · Terminated
Posted results
- Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer
NCT01356862 · Phase 2 · Completed
Linked paper with results
- Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
NCT00088582 · Phase 2 · Completed
Linked paper with results
- Pasireotide Therapy in Patients With Nelson's Syndrome
NCT01617733 · Phase 2 · Terminated
Linked paper with results
- Pasireotide in Hyperinsulinemic Hypoglycemia
NCT03053284 · Phase 2 · Withdrawn
Linked paper with results
- Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
NCT00446082 · Phase 1 · Completed
Linked paper with results
- Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
NCT01372644 · Phase 1 · Completed
Linked paper with results
- Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
NCT02310269 · Phase not stated · Completed
Posted results